| Bradley D Fanestil, MD | |
|
4801 Riverbend Rd Ste 120b, Boulder, CO 80301-2613 | |
| (303) 415-8615 | |
| (303) 293-0628 |
| Full Name | Bradley D Fanestil |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 4801 Riverbend Rd Ste 120b, Boulder, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023156254 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | DR.0031874 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boulder Community Health | 6800707233 | 212 |
News Archive
That number, which reflects the tally of people who obtained insurance via the health law, fell slightly from the estimated 8 million mark that was released in the spring. It means that at least 700,000 consumers who initially signed up for a health plan let it go.
Researchers have discovered a new approach to preventing or treating a stomach bacterium associated with an increased risk of stomach cancer as well as gastritis and duodenal ulcers.
BD (Becton, Dickinson and Company)announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. The acquisition is subject to regulatory approvals and is expected to close during the first quarter of fiscal year 2010. The financial terms of the agreement were not disclosed.
Oncotarget Volume 11 Issue 16 showed that the sensitivity of H1299 and A549 cells to concomitant treatment with PAC and WFA was greater than that of either PAC or WFA alone.
› Verified 1 days ago
| Entity Name | Boulder Community Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821074196 PECOS PAC ID: 6800707233 Enrollment ID: O20040123000284 |
News Archive
That number, which reflects the tally of people who obtained insurance via the health law, fell slightly from the estimated 8 million mark that was released in the spring. It means that at least 700,000 consumers who initially signed up for a health plan let it go.
Researchers have discovered a new approach to preventing or treating a stomach bacterium associated with an increased risk of stomach cancer as well as gastritis and duodenal ulcers.
BD (Becton, Dickinson and Company)announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. The acquisition is subject to regulatory approvals and is expected to close during the first quarter of fiscal year 2010. The financial terms of the agreement were not disclosed.
Oncotarget Volume 11 Issue 16 showed that the sensitivity of H1299 and A549 cells to concomitant treatment with PAC and WFA was greater than that of either PAC or WFA alone.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bradley D Fanestil, MD 5450 Western Ave, Boulder, CO 80301-2709 Ph: (303) 415-4250 | Bradley D Fanestil, MD 4801 Riverbend Rd Ste 120b, Boulder, CO 80301-2613 Ph: (303) 415-8615 |
News Archive
That number, which reflects the tally of people who obtained insurance via the health law, fell slightly from the estimated 8 million mark that was released in the spring. It means that at least 700,000 consumers who initially signed up for a health plan let it go.
Researchers have discovered a new approach to preventing or treating a stomach bacterium associated with an increased risk of stomach cancer as well as gastritis and duodenal ulcers.
BD (Becton, Dickinson and Company)announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. The acquisition is subject to regulatory approvals and is expected to close during the first quarter of fiscal year 2010. The financial terms of the agreement were not disclosed.
Oncotarget Volume 11 Issue 16 showed that the sensitivity of H1299 and A549 cells to concomitant treatment with PAC and WFA was greater than that of either PAC or WFA alone.
› Verified 1 days ago
Ms. Martha E Montour, RN Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 580 Mohawk Dr, Boulder, CO 80303 Phone: 303-440-2690 | |
Chester J Dreiman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2562 Briarwood Dr, Boulder, CO 80305 Phone: 303-501-2195 | |
Pamela G Ingram, MSN Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 580 Mohawk Dr, Boulder, CO 80303 Phone: 303-554-5164 | |
Dr. Joseph Randall Lutt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Folsom St Ste 105, Boulder, CO 80302 Phone: 720-494-4706 Fax: 720-494-4706 | |
Dr. Amy O Campbell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2880 Folsom St Ste 100, Boulder, CO 80304 Phone: 303-327-7047 Fax: 303-443-7168 | |
Wael F. Garas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5495 Arapahoe Ave Ste 100, Boulder, CO 80303 Phone: 303-415-4250 Fax: 303-440-9629 |